Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Latigo Biotherapeutics Inc.

Latigo Biotherapeutics Inc. (LTGO) Stock Overview

Explore Latigo Biotherapeutics Inc.’s financial performance, market position, analyst ratings, and future outlook.

LTGO●NASDAQ
HealthcareMedical - Pharmaceuticals
$22.37
$0.97(4.53%)
U.S. Market opens in 42h 56m

Latigo Biotherapeutics Inc. (LTGO)

Meyka AI Score

Z

Key Financials

Market Cap1.3B
P/E RatioN/A
EPS (TTM)N/A
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

LTGO Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Latigo Biotherapeutics Inc. (NASDAQ: LTGO) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Latigo Biotherapeutics Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of LTGO on the NASDAQ shows an RSI of 87.50, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $N/A for the NASDAQ listing.

Key metrics behind Latigo Biotherapeutics Inc.'s NASDAQ-traded stock include a P/E ratio of N/A and a market capitalization of 1.3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of LTGO on the NASDAQ.

Price Performance (NASDAQ: LTGO)

1-Day Change
4.53%
5-Day Change
11.79%
1-Month Change
24.28%
3-Month Change
24.28%
6-Month Change
24.28%
Year-to-Date (YTD) Change
24.28%
1-Year Change
24.28%
3-Year Change
24.28%
5-Year Change
24.28%
All-Time (Max) Change
24.28%

Contact Information

http://www.latigobio.com
NaN
1300 Rancho Conejo Boulevard, Suite 305, Thousand Oak, CA, 91320

Company Facts

590 Employees
IPO DateAug 7, 2026
CountryUS
Actively Trading

Frequently Asked Questions